论文部分内容阅读
目的:探讨并回顾性分析干扰素致重症血小板减少症的临床救治,为临床预防和治疗相关病症提供科学依据和参考。方法:回顾性分析我院收治的1例干扰素致重症血小板减少症患者治疗及恢复情况。结果:治疗期间诊断发现血小板减少症发生后停止使用干扰素,医护人员根据患者临床诊断检查情况,给予氨甲环酸、维生素K1、止血敏预防出血,补血小板,并给予予醏酸沷泥松刺激血小板升长,治疗取得良好效果,患者现血小板情况恢复正常。结论:使用干扰素发生血小板减少症,应尽早诊断并给予针对性治疗,以提高患者治疗效果以及生活质量。
Objective: To investigate and retrospectively analyze the clinical treatment of interferon-induced severe thrombocytopenia and provide scientific basis and references for clinical prevention and treatment-related disorders. Methods: A retrospective analysis of treatment and recovery of 1 patient with severe thrombocytopenia induced by interferon in our hospital. Results: During the treatment, we found that interferon was stopped after the diagnosis of thrombocytopenia. According to the clinical diagnosis, the medical staff gave tranexamic acid, vitamin K1, hemostatic to prevent bleeding, platelet thrombosis, Stimulate platelet growth, treatment has achieved good results, patients with platelet status returned to normal. Conclusion: The use of interferon in thrombocytopenia should be diagnosed as soon as possible and given targeted treatment to improve patient outcomes and quality of life.